All news

How Veterans Are Helping Advance Marijuana-PTSD Research

The waiting room at the Scottsdale Research Institute in Arizona could be any doctor’s office, except for the faint smell of marijuana.

Study finds cannabis plant could hold key to improving negative symptoms of schizophrenia

An active compound in cannabis plants, once isolated, could be used to treat symptoms of schizophrenia according to findings of a new study.

Marijuana May Be A Weapon Against Brain Aging, Suggests New Study

Since the legalization movement began hitting full stride, new research discoveries about marijuana’s potential health benefits have been surfacing with regularity.

Why Canada's cannabis community needs vapour lounges

“Once legalization comes in, where are people supposed to smoke? In the park, or are they expected to go to an alleyway? Vapour lounges are a much more civilized way of dealing with a problem," says Abi Roach, founder of Hot Box Café.

Cannabis in the treatment of epilepsy

Although cannabis had been used for many centuries for treatment of seizure disorders, medical use became prohibited in the 20th century. However, with the loosening of laws regarding medical marijuana, research and clinical use of marijuana-derived substances are increasing.

Cannabidiol slashes seizures in kids with rare epilepsy, study finds

Cannabidiol, which is found in marijuana plants, reduced the number of convulsive seizures in children with a severe and often fatal epilepsy disorder, according to research published Wednesday in the New England Journal of Medicine.

Tasmanian medicinal cannabis scheme too expensive, patients say

As the Tasmanian Government prepares to spend almost $4 million on a controlled access scheme for medicinal cannabis, some people who already use the drug have raised concerns about the scheme's effectiveness.

Medicinal cannabis should be more easily available, says GP

Katoomba GP, Teresa Towpik, is singing the praises of medicinal cannabis.

AusCann Group Holdings secures medical cannabis funding

AusCann Group Holdings (ASX:AC8) has raised $12 million through the placement of 24 million shares priced at $0.50 to institutional and high net worth investors. Significantly, the placement price is more than double the price of the company’s ASX debut in February of $0.20.

First legal, commercial medicinal cannabis shipment now in Australia

The first two commercial shipments of medicinal cannabis products to be legally imported to Australia have arrived in Melbourne and Perth.